Founded in 2007, Klea Holding is a group focused on acquiring, developing and digitizing companies in various sectors to maximize their growth and value. Through its "scaling industries of the future" identity, Klea Holding draws on its successful experience in developing Smart Salem, the first network of digitalized medical analysis centers accredited by the Dubai Ministry of Health (DHA) in the United Arab Emirates, its joint venture Smart Health, dedicated to the roll-out of digital medical testing centres in Saudi Arabia; and Klea Pharmaceuticals, a subsidiary dedicated to the commercialisation of a portfolio of licensed medicines in the Middle East and Africa.

Employees

112

Sector

Healthcare Facilities & Services

More about the company

Quotes

Date	Price	Change	Volume
10/11/26	€0.1716	+6.58%	334,769
09/11/26	€0.1610	+2.03%	208,284
06/11/26	€0.1578	+0.90%	147,933
05/11/26	€0.1564	+1.16%	198,671
04/11/26	€0.1546	+7.81%	201,459

Real-time Euronext Paris

More quotes

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Klea Holding

Company calendar

Market Closed - Euronext Paris 16:55:00 10/11/2026 GMT			After hours 20:10:56
0.1716 ^EUR	+6.58%		0.1720	+0.23%

10-21	Klea Holding SA Reports Earnings Results for the Half Year Ended June 30, 2026	CI
10-08	Klea Holding Sa Confirms Earnings Guidance for the Year 2026	CI

Market Cap	49.43M 55.11M 45.55M 41.37M 78.29M 5.17B 80.48M 545M 217M 2.77B 207M 202M 8.75B	P/E 2024	44.3x	P/E 2025	31.3x
Enterprise Value	49.55M 55.25M 45.67M 41.47M 78.49M 5.18B 80.68M 547M 218M 2.78B 207M 203M 8.77B	EV / Sales 2024	3.3x	EV / Sales 2025	3.04x
Free-Float	99.83%	Yield 2024 *	-	Yield 2025	-

Markets		Quality
Euronext Paris	ALKLH	Real-time
Deutsche Boerse AG	7V91	Delayed
Börse Stuttgart	7V91	Delayed
Boerse Muenchen	7V91	Real-time
Tradegate	7V91	Real-time

10-21	Klea Holding SA Reports Earnings Results for the Half Year Ended June 30, 2026	CI
10-08	Klea Holding Sa Confirms Earnings Guidance for the Year 2026	CI
10-08	Klea Holding Sa Reports Unaudited Consolidated Sales Results for the Third Quarter of 2026	CI
09-10	Klea Pharmaceuticals Receives First Order from Alphamed and Expands Distribution in the Middle East	CI
09-09	Klea Holding Launches Wellness Brand in Dubai	MT
09-08	Klea Holding's Smart Health Unit to Open First Digital Medical Center in Saudi Arabia in Few Weeks	MT
09-07	Klea Holding Provides Update on the Opening of the 1St Digital Medical Centre in Riyadh	CI
08-11	Klea Holding SA Reports Unaudited Consolidated Sales Results for the first half of 2026	CI
07-29	EQT to sell Quantios to Vista Equity Partners	FW
07-15	Klea Holding targets improved profitability in the second half
06-11	Klea Holding SA Announces the Launch of Its New Subsidiary, Klea Pharmaceuticals	CI
06-11	Klea Launches Medicine Distribution Business for Middle East, Africa	MT
06-11	Klea Holding announces the launch of its new subsidiary

Klea Holding Share Price

Stocks

ALKLH

FR0013481835

Healthcare Facilities & Services

Valuation: Klea Holding

Chart: Klea Holding

Latest news: Klea Holding

Analysts' recommendations: Klea Holding

Press Releases: Klea Holding

News in other languages: Klea Holding

Quotes and Performance

Price Extremes

Managers and Directors: Klea Holding

Latest insider transactions

Other Healthcare Facilities & Services

Financials

Company Profile

Quotes

Annual profits - Rate of surprise

10-08	Klea : confirms its gradual rebound in Q3 2026 and targets revenue growth in Q4 2026	PU
10-08	Klea Holding : Klea Holding confirms its gradual rebound in Q3 2026 and targets revenue growth in Q4 2026	AT
09-28	Klea : Still profitable in H1 2026, Klea Holding invests in its future growth drivers	PU
09-28	Klea Holding : Still profitable in H1 2026, Klea Holding invests in its future growth drivers	AT
09-10	Klea : Pharmaceuticals secures its first order and reaffirms its ambitions for strong and profitable growth	PU

10-30	Klea : DeclarationDirigeants
10-30	Klea : DeclarationDirigeants
10-30	Klea : DeclarationDirigeants
10-30	Klea : DeclarationDirigeants
10-30	Klea : DeclarationDirigeants

1 day	+6.58%
1 week	+19.67%
Current month	+8.61%
1 month	+45.42%
3 months	+9.16%
6 months	-10.34%
Current year	-21.64%

1 week	0.14	0.17
1 month	0.1	0.17
Current year	0.1	0.25
1 year	0.1	0.26
3 years	0.1	0.34
5 years	0.08	0.59
10 years	0.08	149.6

Manager	Title	Age	Since
Raphael Smila CEO	Chief Executive Officer	-	09/06/2025
Jérôme Fabreguettes-Leib IRC	Investor Relations Contact	-	-

Date	Insider	Type	Quantity	% Market Cap.
17/07/26	Raphael Smila	Buy	103,000	0.0335%
17/07/26	Raphael Smila	Buy	103,000	0.0335%
16/07/26	Raphael Smila	Buy	87,000	0.0283%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
KLEA HOLDING	+6.58%	+19.67%	-28.80%	-40.83%	55.37M
CVS HEALTH CORPORATION	+3.44%	-3.49%	+13.77%	+30.35%	109B
HCA HEALTHCARE, INC.	-0.39%	+8.61%	+9.45%	+115.92%	105B
NATERA, INC.	-2.38%	-19.39%	+51.62%	+570.28%	46.46B
FRESENIUS SE & CO. KGAA	+1.83%	+8.03%	+10.16%	+105.72%	33.1B
LABCORP HOLDINGS INC.	-0.21%	+4.97%	+42.27%	+81.42%	30.19B
QUEST DIAGNOSTICS INCORPORATED	-0.49%	+4.87%	+40.57%	+95.07%	28.57B
TENET HEALTHCARE CORPORATION	-0.07%	+8.43%	+48.54%	+437.59%	23B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+0.23%	+1.42%	-17.61%	-15.87%	19.97B
IHH HEALTHCARE	+0.52%	-1.40%	-6.52%	+30.30%	16.76B
Average	+0.92%	+1.49%	+16.35%	+141.00%	41B
Weighted average by Cap.	+0.67%	+0.94%	+20.17%	+147.72%

	2024	2025
Net sales	17.26M 19.25M 15.91M 14.45M 27.34M 1.8B 28.1M 190M 75.88M 967M 72.23M 70.7M 3.06B	22.17M 24.72M 20.43M 18.55M 35.11M 2.32B 36.09M 245M 97.45M 1.24B 92.76M 90.79M 3.93B
Net income	1.4M 1.57M 1.29M 1.18M 2.23M 147M 2.29M 15.5M 6.18M 78.7M 5.88M 5.75M 249M	2.28M 2.54M 2.1M 1.91M 3.61M 238M 3.71M 25.17M 10.03M 128M 9.55M 9.34M 404M
Net Debt	2.58M 2.87M 2.37M 2.16M 4.08M 269M 4.19M 28.41M 11.32M 144M 10.78M 10.55M 456M	125K 139K 115K 105K 198K 13.07M 204K 1.38M 550K 7M 523K 512K 22.13M